{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:05:57Z","timestamp":1791594357007,"version":"4.3.4"},"reference-count":64,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Numerous studies have tried to evaluate the potential role of thrombophilia-related genes in retinal vein occlusion (RVO); however, there is limited research on genes related to different pathophysiological mechanisms involved in RVO. In view of the strong contribution of oxidative stress and inflammation to the pathogenesis of RVO, the purpose of the present study was to investigate the association of inflammation- and oxidative-stress-related polymorphisms from three different genes [apolipoprotein E (APOE), paraoxonase 1 (PON1) and stromal cell-derived factor 1 (SDF-1)] and the risk of RVO in a Greek population. Participants in this case-control study were 50 RVO patients (RVO group) and 50 healthy volunteers (control group). Blood samples were collected on EDTA tubes and genomic DNA was extracted. Genotyping of rs854560 (L55M) and rs662 (Q192R) for the PON1 gene, rs429358 and rs7412 for the APOE gene and rs1801157 [SDF1-3\u2032G(801)A] for SDF-1 gene was performed using the polymerase chain reaction\u2013restriction fragment length polymorphism (PCR-RFLP) method. Multiple genetic models (codominant, dominant, recessive, overdominant and log-additive) and haplotype analyses were performed using the SNPStats web tool to assess the correlation between the genetic polymorphisms and the risk of RVO. Binary logistic regression analysis was used for the association analysis between APOE gene variants and RVO. Given the multifactorial nature of the disease, our statistical analysis was adjusted for the most important systemic risk factors (age, hypertension and diabetes mellitus). The dominant genetic model for the PON1 Q192R single nucleotide polymorphism (SNP) of the association analysis revealed that there was a statistically significant difference between the RVO group and the control group. Specifically, after adjusting for age and hypertension, the PON1 192 R allele (QR + RR) was found to be associated with a statistically significantly higher risk of RVO compared to the QQ genotype (OR = 2.51; 95% CI = 1.02\u20136.14, p = 0.04). The statistically significant results were maintained after including diabetes in the multivariate model in addition to age and hypertension (OR = 2.83; 95% CI = 1.01\u20137.97, p = 0.042). No statistically significant association was revealed between the other studied polymorphisms and the risk of RVO. Haplotype analysis for PON1 SNPs, L55M and Q192R, revealed no statistically significant correlation. In conclusion, PON1 192 R allele carriers (QR + RR) were associated with a statistically significantly increased risk of RVO compared to the QQ homozygotes. These findings suggest that the R allele of the PON1 Q192R is likely to play a role as a risk factor for retinal vein occlusion.<\/jats:p>","DOI":"10.3390\/genes15060712","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T10:06:01Z","timestamp":1717409161000},"page":"712","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PON1, APOE and SDF-1 Gene Polymorphisms and Risk of Retinal Vein Occlusion: A Case-Control Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7133-8357","authenticated-orcid":false,"given":"Antonios","family":"Ragkousis","sequence":"first","affiliation":[{"name":"2nd Department of Ophthalmology, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kazantzis","sequence":"additional","affiliation":[{"name":"2nd Department of Ophthalmology, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Georgalas","sequence":"additional","affiliation":[{"name":"1st Department of Ophthalmology, \u201cG. Gennimatas\u201d General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Theodossiadis","sequence":"additional","affiliation":[{"name":"2nd Department of Ophthalmology, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5876-2599","authenticated-orcid":false,"given":"Christos","family":"Kroupis","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8523-1024","authenticated-orcid":false,"given":"Irini","family":"Chatziralli","sequence":"additional","affiliation":[{"name":"2nd Department of Ophthalmology, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000494224","article-title":"Prevalence of Retinal Vein Occlusion in Europe: A Systematic Review and Meta-Analysis","volume":"241","author":"Li","year":"2019","journal-title":"Ophthalmologica"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"010427","DOI":"10.7189\/jogh.09.010427","article-title":"Global epidemiology of retinal vein occlusion: A systematic review and meta-analysis of prevalence, incidence, and risk factors","volume":"9","author":"Song","year":"2019","journal-title":"J. Glob. Heal."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s40123-022-00534-7","article-title":"Clinical Features of Central Retinal Vein Occlusion in Young Patients","volume":"11","author":"Zhang","year":"2022","journal-title":"Ophthalmol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s40123-023-00829-3","article-title":"Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study","volume":"13","author":"Donati","year":"2024","journal-title":"Ophthalmol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2147\/OPTH.S7631","article-title":"Retinal vein occlusion: Pathophysiology and treatment options","volume":"4","author":"Karia","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"910600","DOI":"10.3389\/fmed.2022.910600","article-title":"Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion","volume":"9","author":"Tang","year":"2022","journal-title":"Front. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000381357","article-title":"Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus","volume":"234","author":"Berger","year":"2015","journal-title":"Ophthalmologica"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Penman, A.D., Crowder, K.W., and Watkins, W.M. (2020). 50 Studies Every Ophthalmologist Should Know, Oxford University Press.","DOI":"10.1093\/med\/9780190050726.001.0001"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"108255","DOI":"10.1016\/j.exer.2020.108255","article-title":"The role of reactive oxygen species in the pathogenesis and treatment of retinal diseases","volume":"201","author":"Chan","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Cehofski, L.J., Honor\u00e9, B., and Vorum, H. (2017). A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18050907"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Romanitan, M.O., Popa-Cherecheanu, M., Vasile, V.A., Stanca, S., Iancu, G., Zemba, M., Branisteanu, D., Iancu, R., and Pirvulescu, R.A. (2023). Highlights on Genetic Polymorphism Associated with Thromboembolic Risk; Implications in Ophthalmic and Autoimmune Disorders\u2014A Review. Diagnostics, 13.","DOI":"10.3390\/diagnostics13071267"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI","volume":"31","author":"Hixson","year":"1990","journal-title":"J. Lipid Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Szigeti, A., Ecsedy, M., Schneider, M., L\u00e9n\u00e1rt, L., Lesch, B., Nagy, Z.Z., Fekete, A., and R\u00e9cs\u00e1n, Z. (2016). Stromal Cell-Derived Factor 1 Polymorphism in Retinal Vein Occlusion. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166544"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11010-012-1525-2","article-title":"Paraoxonase 1 L55M, Q192R and paraoxonase 2 S311C alleles in atherothrombosis","volume":"374","author":"Cozzi","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1161\/01.ATV.17.12.3565","article-title":"A 192 Arg Variant of the Human Paraoxonase (HUMPONA) Gene Polymorphism Is Associated with an Increased Risk for Coronary Artery Disease in the Japanese","volume":"17","author":"Zama","year":"1997","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: A web tool for the analysis of association studies","volume":"22","author":"Valls","year":"2006","journal-title":"Bioinformatics"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Lendzioszek, M., Mrugacz, M., Bryl, A., Poppe, E., and Zorena, K. (2023). Prevention and Treatment of Retinal Vein Occlusion: The Role of Diet\u2014A Review. Nutrients, 15.","DOI":"10.3390\/nu15143237"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lee, J.H., Kim, S.H., and Kim, E. (Ophthalmic Epidemiol., 2024). Influence of Smoking and Controlled Medical Conditions on the Risks of Branch Retinal Vein Occlusion in South Korea: A Population-Based Study, Ophthalmic Epidemiol., Online ahead of print.","DOI":"10.1080\/09286586.2024.2321902"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.oret.2022.03.012","article-title":"Association between Retinal Vein Occlusion and Life\u2019s Simple 7 Cardiovascular Health Metrics: A Large Claims Database Study","volume":"6","author":"Hashimoto","year":"2022","journal-title":"Ophthalmol. Retin."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1160\/TH07-11-0658","article-title":"The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis","volume":"99","author":"Rehak","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/13816810.2012.746376","article-title":"Genetic polymorphisms associated with retinal vein occlusion: A Greek case-control study and me-ta-analysis","volume":"34","author":"Yioti","year":"2013","journal-title":"Ophthalmic Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3109\/02713683.2013.820329","article-title":"Role of the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) \u22121639G>A Gene Polymorphism in Patients with Retinal Vein Occlusion","volume":"38","author":"Weger","year":"2013","journal-title":"Curr. Eye Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1442-9071.2012.02780.x","article-title":"Predictive value of the vitamin K epoxide reductase complex subunit 1 G-1639A and C1173T single nucleotide polymorphisms in retinal vein occlusion","volume":"40","author":"Ortak","year":"2012","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1111\/jth.15068","article-title":"Inherited and acquired thrombophilia in adults with retinal vascular occlusion: A systematic review and meta-analysis","volume":"18","author":"Romiti","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00001721-199810000-00008","article-title":"Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion","volume":"9","author":"Salomon","year":"1998","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0049-3848(03)00293-7","article-title":"Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion","volume":"110","author":"Marcucci","year":"2003","journal-title":"Thromb. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000360013","article-title":"Thrombophilia in patients with retinal vein occlusion: A retrospective analysis","volume":"232","author":"Risse","year":"2014","journal-title":"Ophthalmologica"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/1076029614522544","article-title":"Thrombophilic Mutations as Risk Factor for Retinal Vein Occlusion: A Case\u2013Control Study","volume":"21","author":"Russo","year":"2014","journal-title":"Clin. Appl. Thromb."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-9560-3-13","article-title":"Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion","volume":"3","author":"Ferrazzi","year":"2005","journal-title":"Thromb. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.ophtha.2009.02.033","article-title":"Homocysteine, Methylenetetrahydrofolate Reductase C677T Polymorphism, and Risk of Retinal Vein Occlusion: A Meta-analysis","volume":"116","author":"McGimpsey","year":"2009","journal-title":"Ophthalmology"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Li, D., Zhou, M., Peng, X., and Sun, H. (2014). Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: An updated meta-analysis. BMC Ophthalmol., 14.","DOI":"10.1186\/1471-2415-14-147"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0002-9394(03)00571-3","article-title":"Meta-analysis of plasma homocysteine, serum folate, serum vitamin B12, and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease","volume":"136","author":"Cahill","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1160\/TH04-11-0768","article-title":"Retinal vein occlusion: A form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors","volume":"93","author":"Heijer","year":"2005","journal-title":"Thromb. Haemost."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.transci.2013.12.016","article-title":"Association of methylenetetrahydrofolate reductase (A1298C and C677T) polymorphisms with retinal vein occlusion in Tunisian patients","volume":"50","author":"Mrad","year":"2014","journal-title":"Transfus. Apher. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MBC.0b013e32835bfda1","article-title":"Retinal vein occlusion","volume":"24","author":"Giannaki","year":"2013","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s10792-019-01113-9","article-title":"Genetic polymorphisms associated with the prevalence of retinal vein occlusion in a Greek population","volume":"39","author":"Christodoulou","year":"2019","journal-title":"Int. Ophthalmol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-9560-12-17","article-title":"Relationship between angiotensin I-converting enzyme insertion\/deletion gene polymorphism and retinal vein occlusion","volume":"12","author":"Kutluturk","year":"2014","journal-title":"Thromb. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00417-007-0617-2","article-title":"807C\/T polymorphism in platelet glycoprotein Ia gene is not associated with retinal vein occlusion","volume":"245","author":"Gadelha","year":"2007","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.eye.6700452","article-title":"The platelet glycoprotein Ia\/IIa gene polymorphism C807T\/G873A: A novel risk factor for retinal vein occlusion","volume":"17","author":"Dodson","year":"2003","journal-title":"Eye"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.exer.2013.06.009","article-title":"Association of MMP2-1306C\/T and TIMP2G-418C polymorphisms in retinal vein occlusion","volume":"113","author":"Ortak","year":"2013","journal-title":"Exp. Eye Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1097\/IAE.0000000000000580","article-title":"Genetic Association between Arterial Stiffness-Related Gene Polymorphisms in Brvo and Crvo Patients in a Turkish Population","volume":"35","author":"Demir","year":"2015","journal-title":"Retina"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.arcmed.2020.06.015","article-title":"Association of MMP2-1306C\/T Polymorphism with Ischemic Retinal Vein Occlusion","volume":"51","author":"Christodoulou","year":"2020","journal-title":"Arch. Med. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/13816810.2022.2092754","article-title":"Heme oxygenase-1 gene rs2071746 polymorphism in retinal vein occlusion","volume":"43","author":"List","year":"2022","journal-title":"Ophthalmic Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ophtha.2010.10.014","article-title":"Role of Inflammation-Related Gene Polymorphisms in Patients with Central Retinal Vein Occlusion","volume":"118","author":"Maier","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11883-021-00933-4","article-title":"Apolipoprotein E and Atherosclerosis","volume":"23","author":"Marais","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Puthia, M., Marzinek, J.K., Petruk, G., Bergdahl, G.E., Bond, P.J., and Petrlova, J. (2022). Antibacterial and Anti-Inflammatory Effects of Apolipoprotein E. Biomedicines, 10.","DOI":"10.3390\/biomedicines10061430"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/eurheartj\/ehz402","article-title":"Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort","volume":"40","author":"Rasmussen","year":"2019","journal-title":"Eur. Hear. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/1076029616629212","article-title":"Role of the Apolipoprotein E Polymorphisms in the Development of Retinal Vein Occlusion in a Tunisian Population: A Case\u2013Control Study","volume":"23","author":"Mrad","year":"2017","journal-title":"Clin. Appl. Thromb."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archopht.125.6.813","article-title":"Apolipoprotein E Gene Polymorphisms and Retinal Vascular Signs: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"125","author":"Liew","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Hu, M.L., Quinn, J., and Xue, K. (2021). Interactions between Apolipoprotein E Metabolism and Retinal Inflammation in Age-Related Macular Degeneration. Life, 11.","DOI":"10.3390\/life11070635"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.arcmed.2017.08.002","article-title":"Association of Apolipoprotein E Polymorphisms with Age-related Macular Degeneration Subtypes: An Updated Systematic Review and Meta-analysis","volume":"48","author":"Xiying","year":"2017","journal-title":"Arch. Med. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1096\/fj.06-7359com","article-title":"The SDF-1\/CXCR4 ligand\/receptor pair is an important contributor to several types of ocular neovascularization","volume":"21","author":"Shen","year":"2007","journal-title":"FASEB J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1007\/s11033-021-07069-3","article-title":"The significance of the SDF-1\/CXCR4 signaling pathway in the normal development","volume":"49","author":"Sadri","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/02713680701758727","article-title":"Stromal-Derived Factor-1 and Inflammatory Cytokines in Retinal Vein Occlusion","volume":"32","author":"Arimura","year":"2007","journal-title":"Curr. Eye Res."},{"key":"ref_55","first-page":"756","article-title":"Comprehensive analysis of vitreous chemokines involved in ischemic retinal vein occlusion","volume":"25","author":"Zeng","year":"2022","journal-title":"Mol. Vis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"792090","DOI":"10.1155\/2013\/792090","article-title":"Functionally defective high-density lipoprotein and paraoxonase: A couple for endothelial dysfunction in atherosclerosis","volume":"2013","author":"Eren","year":"2013","journal-title":"Cholesterol"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gene.2015.04.088","article-title":"Human Paraoxonase-1 (PON1): Gene Structure and Expression, Promiscuous Activities and Multiple Physiological Roles","volume":"567","author":"Mackness","year":"2015","journal-title":"Gene"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Kunachowicz, D., \u015aciskalska, M., and Kepinska, M. (2023). Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review. Int. J. Environ. Res. Public Heal., 20.","DOI":"10.3390\/ijerph20042813"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1065967","DOI":"10.3389\/fcvm.2023.1065967","article-title":"Paraoxonase 1 and atherosclerosis","volume":"10","author":"Durrington","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Valencia, C.S., Isaza, M.C., Henao, B.J., Beltr\u00e1n, A.L., Loango, N., and Land\u00e1zuri, P. (2021). Arylesterase activity of paraoxonase 1 (PON1) on HDL3 and HDL2: Relationship with Q192R, C-108T, and L55M polymorphisms. Biochem. Biophys. Rep., 26.","DOI":"10.1016\/j.bbrep.2021.100971"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.eye.6703062","article-title":"Serum PON1 arylesterase activity in relation to hyperhomocysteinaemia and oxidative stress in young adult central retinal venous occlusion patients","volume":"22","author":"Angayarkanni","year":"2008","journal-title":"Eye"},{"key":"ref_62","first-page":"486","article-title":"Protective effect of paraoxonase 1 gene variant L55M in retinal vein occlusion","volume":"19","author":"Ortak","year":"2013","journal-title":"Mol. Vis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/08820538.2023.2283028","article-title":"Association of PON1, APOE and SDF-1 Gene Polymorphisms with Treatment Response to Intravitreal Anti-VEGF Treatment in Patients with Retinal Vein Occlusion","volume":"39","author":"Ragkousis","year":"2024","journal-title":"Semin. Ophthalmol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000027303","article-title":"Molecular Variant of the Human Paraoxonase\/Arylesterase Gene Is Associated with Central Retinal Vein Occlusion in the Japanese Population","volume":"212","author":"Murata","year":"1998","journal-title":"Ophthalmologica"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/6\/712\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:50:49Z","timestamp":1760107849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/6\/712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["genes15060712"],"URL":"https:\/\/doi.org\/10.3390\/genes15060712","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}